🔎 Trials Near Me

Akèy › BPCO › North Carolina › Winston-Salem

Etid klinik pou BPCO nan Winston-Salem, NC

9 etid pou BPCO ap chèche patisipan nan sit nan ak bò kote Winston-Salem (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Ap rekriteFaz 3
  • All-Trials Clinical Research- Site Number : 8400008, Winston-Salem
Laj 40 a 80 · Tout sèks · Mizajou Oct 1, 2026 · NCT07190222

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Ap rekriteFaz 3
  • Atrium Health Wake Forest Baptist Pulmonary, Sleep And Allergy- Site Number : 8400048, Winston-Salem
Laj 40 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07190209

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

Ap rekriteFaz 4
  • Atrium Health Wake Forest Baptist Pulmonary, Sleep And Allergy- Site Number : 8400004, Winston-Salem
Laj 40 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07053423

Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD

Ap rekriteFaz 4
  • Southeastern Research Center, Winston-Salem
Laj 60 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07816835

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Ap rekriteFaz 3
  • Research Site, Winston-Salem
Laj 40 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Ap rekriteFaz 2/3
  • Salem Chest Specialists, Winston-Salem
  • Southeastern Research Center, Winston-Salem
Laj 35 a 80 · Tout sèks · Mizajou Aug 31, 2026 · NCT07363694

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

Ap rekriteFaz 3
  • GSK Investigational Site, Winston-Salem
Laj 40 a 75 · Tout sèks · Mizajou Jul 28, 2026 · NCT07177339

SPIROMICS Study of Early COPD Progression (SOURCE)

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Wake Forest, Winston-Salem
Laj 30 a 55 · Tout sèks · Mizajou Jun 3, 2026 · NCT05033990

Etid BPCO nan lòt vil

Lòt etid nan Winston-Salem

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.